Brensocatib leads to lower rate of pulmonary exacerbations in bronchiectasis
For patients with bronchiectasis, brensocatib leads to a lower annualized rate of pulmonary exacerbations, according to a study published in the April 24 issue of the New England Journal of Medicine.
Post Views: 22
